Sec Form 4 Filing - Frost Ronald @ MERIT MEDICAL SYSTEMS INC - 2018-11-07

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Frost Ronald
2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Operating Officer
(Last) (First) (Middle)
1600 WEST MERIT PARKWAY
3. Date of Earliest Transaction (MM/DD/YY)
11/07/2018
(Street)
SOUTH JORDAN, UT84095
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value 16,239 I By 401(k) plan ( 1 )
Common Stock, No Par Value 11/07/2018 M 5,257 A $ 13.14 5,257 D
Common Stock, No Par Value 11/07/2018 S 5,257 D $ 61.308 ( 2 ) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy) $ 13.14 11/07/2018 M 5,257 07/31/2014( 3 ) 07/31/2020 Common Stock 5,257 $ 0 4,743 D
Non-qualified stock options (right to buy) $ 12.06 10/04/2015( 4 ) 10/04/2021 Common Stock 25,000 25,000 D
Non-qualified stock options (right to buy) $ 17.27 02/13/2016( 5 ) 02/13/2022 Common Stock 20,000 20,000 D
Non-qualified stock options (right to buy) $ 16.05 01/28/2017( 6 ) 01/28/2023 Common Stock 20,000 20,000 D
Non-qualified stock options (right to buy) $ 28.2 04/14/2018( 7 ) 04/14/2024 Common Stock 50,000 50,000 D
Non-qualified stock options (right to buy) $ 44.8 03/02/2019( 8 ) 03/02/2025 Common Stock 40,000 40,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Frost Ronald
1600 WEST MERIT PARKWAY
SOUTH JORDAN, UT84095
Chief Operating Officer
Signatures
Brian G. Lloyd, Attorney-in-Fact 11/09/2018
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Represents plan holdings as of 11/07/2017.
( 2 )The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.30 to $61.35, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
( 3 )Became exercisable in equal annual installments of 20% commencing 07/31/2014.
( 4 )Become exercisable in equal annual installments of 20% commencing 10/04/2015.
( 5 )Become exercisable in equal annual installments of 20% commencing 02/13/2016.
( 6 )Become exercisable in equal annual installments of 20% commencing 01/28/2017.
( 7 )Become exercisable in equal annual installments of 20% commencing 04/14/2018.
( 8 )Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.